Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 2

The relationship of multiple HPV DNA positivity with colposcopic biopsy results

Çoklu HPV DNA pozitifliğinin kolposkopik biyopsi sonuçları ile ilişkisi

Dilek Buldum(ISTANBUL UNIVERSITY-CERRAHPASA, CERRAHPAŞA SCHOOL OF MEDICINE)0000-0001-6328-1055
Şefik Eser Özyürek(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ)0000-0002-5373-3991
Önder Aydın(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ)0000-0001-5876-2831
Nurşen Kurtoğlu(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAĞCILAR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-8609-4487
Pages
—
Publication Date
2026-03-12
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Larger, prospective studies are needed to better clarify the clinical impact of multiple HPV infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: This study aimed to investigate the association between multiple HPV DNA positivity and the presence of high-grade cervical intraepithelial lesions or cervical cancer.
📊
Key Findings & Data:Methods: The medical records of 164 patients who underwent colposcopic biopsy in the department of obstetrics and gynecology were retrospectively reviewed.
💡
Conclusion & Impact:Larger, prospective studies are needed to better clarify the clinical impact of multiple HPV infections.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Multiple HPV infection · cervical cancer · human papillomavirus

Abstract

Aims: This study aimed to investigate the association between multiple HPV DNA positivity and the presence of high-grade cervical intraepithelial lesions or cervical cancer. Methods: The medical records of 164 patients who underwent colposcopic biopsy in the department of obstetrics and gynecology were retrospectively reviewed. PAP smear results (LGSIL, ASCUS, ASC-H), HPV test positivity, and HPV genotypes were evaluated. Based on colposcopic biopsy findings, patients were categorized into two groups: group I: negative, LSIL, koilocytosis, and CIN I; group II: HSIL, CIN II–III, and squamous cell carcinoma. Results: No statistically significant association was found between the presence of multiple HPV genotypes, single HPV genotype positivity, and colposcopic biopsy outcomes. Additionally, demographic factors such as age, parity, and menstrual status were not associated with high-grade cervical lesion development. Conclusion: The present study does not provide evidence that multiple HPV infections increase the risk of cervical dysplasia or cervical cancer. Larger, prospective studies are needed to better clarify the clinical impact of multiple HPV infections.

Özet

Amaç: Bu çalışmada çoklu HPV DNA pozitifliklerinin servikal yüksek dereceli lezyonlarla veya servikal kanserle ilişkisinin araştırılması amaçlanmıştır. Gereçler ve Yöntem: Kadın Hastalıkları ve Doğum Kliniği’nde kolposkopik biyopsi uygulanmış 164 hastanın medikal kayıtları retrospektif olarak analiz edilerek, PAP smear sonucu: (LGSIL - ASCUS - ASC-H)-HPV testi (pozitif) - HPV alt tiplemeleri incelenmiştir. Olgular ; Grup I (negatif, LSIL, koilositoz ve CIN I) ve Grup II (HSIL, CIN II-III, skuamöz karsinom) olmak üzere 2 gruba ayrılmıştır. Bulgular: Çalışma sonucunda hastaların bazı demografik özellikleri (yaş, parite, menstruasyon durumu), çoklu veya tekli HPV alt tipleri açısından pozitif olma durumları ile kolposkopik biyopsi sonuçları arasında istatistiksel olarak anlamlı fark saptanmamıştır. Sonuç: Çoklu HPV enfeksiyonlarının servikal displazi ve kanser üzerindeki etkisini aydınlatmak için daha büyük kohortları içeren çalışmalara ihtiyaç vardır. Anahtar Kelimeler: Çoklu HPV enfeksiyonu, Rahim ağzı kanseri, İnsan papilloma virüsü, Tarama Kısaltmalar: HPV, Human papilloma virus; PAP, Papanicolaous; CIN, Cervical intraepithelial neoplasms; LSIL, Low grade squamous intraepithelial lesion; HSIL, High grade squamous intraepithelial lesion; ASCUS, Atypical squamous cell of undetermined significance; ASC-H, Atypical squamous cell- cannot exclude HSIL

🔖

Cite This Article

Buldum, D., Özyürek, Ş. E., Aydın, Ö., Kurtoğlu, N. (2026). The relationship of multiple HPV DNA positivity with colposcopic biopsy results. Journal of Health Sciences and Medicine, Volume: 9 Issue: 2. https://doi.org/10.32322/jhsm.1840460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (28)

  1. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191-203. doi:10.1016/S2214-109X(19)30482-6
  2. Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases in the World. Summary Report 2023. Institut Català d’Oncologia. 2023.
  3. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1-30.
  4. Arbyn M, Sasieni P, Meijer C, Clavel C, Koliopoulos G, Dillner J. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24(Suppl 3):S3/78-89. doi:10.1016/j.vaccine.2006.05.115
  5. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1274-1280. doi:10.1158/1055-9965.EPI-06-0129
  6. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Cancer. Fact Sheet 2023. Institut Català d’Oncologia, Barcelona, Spain. 2023.
  7. Dursun P, Ayhan A, Mutlu L, Güngör M, Haberal A. Servikal kanser öncülü lezyonlarda HPV tip dağılımı. Turk Patoloji Derg. 2013;29:210-216. doi:10.5146/tjpath.2013.01178
  8. Bruno MT, Scalia G, Cassaro N, Boemi S. Multiple HPV 16 infection with two strains: a possible neoplastic progression marker. BMC Cancer. 2020;20(1):444. doi:10.1186/s12885-020-06916-9
  9. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527. doi:10.1056/NEJMoa021641
  10. Paavonen J, Naud P, Salmerón J, et al. Efficacy of HPV-16/18 AS04-adjuvanted vaccine (PATRICIA). Lancet. 2009;374:301-314. doi:10.1016/S0140-6736(09)61248-4
  11. Karabulutlu Ö, Pasinlioğlu T. Alanı sağlıkla ilgili olmayan akademisyenlerin serviks kanserine ilişkin bilgi düzeyleri. Kafkas Tıp Bilimleri Derg. 2016;6(3):175-180.
  12. Nayar R, Wilbur DC. The Pap test and Bethesda 2014 classification system. Cancer Cytopathol. 2015;123(5):271-281. doi:10.1002/cncy.21521
  13. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-based management guidelines. J Low Genit Tract Dis. 2020;24(4):427-434. doi: 10.1097/LGT.0000000000000525
  14. Hoorry T, Monie A, Gravitt P, Wu TC. Molecular epidemiology of human papillomavirus. J Formos Med Assoc. 2008;107:198-217. doi:10. 1016/S0929-6646(08)60138-7
  15. Benedet JL, Matisic JP, Bertrand MA. Analysis of 84,244 patients in the BC screening program. Gynecol Oncol. 2004;92:127-134. doi:10.1016/j.ygyno.2003.09.019
  16. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. HPV types in invasive cervical cancer worldwide. Br J Cancer. 2003;88:63-73. doi: 10.1038/sj.bjc.6600688
  17. Walboomers JMM, Jacobs MV, Manos MM, et al. HPV is a necessary cause of invasive cervical cancer. J Pathol. 1999;189(1):12-19. doi:10.1002/(SICI)1096-9896(199909)189:1 3.0.CO;2-F
  18. Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM. Role of HPV genotype and viral load. Cancer Epidemiol Biomarkers Prev. 2019; 28:1816-1824. doi:10.1158/1055-9965.EPI-18-1335
  19. Luo Q, Li H, Liu Y, et al. HPV prevalence among women in China. BMC Infect Dis. 2023;23:667. doi:10.1186/s12879-023-08486-z
  20. Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital HPV. J Clin Microbiol. 2013;51:1458-1464. doi: 10.1128/JCM.00025-13
  21. Wentzensen N, Schiffman M, Dunn T, et al. Multiple HPV genotype infections andcarcinogenesis. Int J Cancer. 2009;125:21512158. doi:10. 1002/ijc.24596
  22. Li M, Li P, Yang Y, Liu M, Zhang J. Prevalence of HPV infection among Chinese women. J Med Virol. 2019;91:473-481. doi:10.1002/jmv.25341
  23. Alci A, Gorkem U, Ayas S, Togrul C. HPV genotype distribution in Turkish women. Med Bull Sisli Etfal Hosp. 2025;59(3):338-344.
  24. Salazar KL, Zhou HS, Xu J, et al. Multiple HPV infections and high-risk lesions. Acta Cytol. 2015;59(5):391-398. doi:10.1159/000439444
  25. Herrero R. HPV vaccines: limited cross-protection. J Infect Dis. 2009; 199:919-922. doi:10.1086/597043
  26. Fife KH, Cramer HM, Schroeder JM, Brown DR. The detection of multiple HPV types correlates with dysplasia. J Med Virol. 2001;64:550-559. doi:10.1002/jmv.1084
  27. Kulhan M, Kulhan NG, Nayki C, Nayki U, Atağ F, Ulug P. HPV genotype distribution and mRNA expression levels. Contemp Oncol (Pozn). 2017;21(3):218-223. doi:10.5114/wo.2017.68618
  28. Zhou H, Mody DR, Schwartz MR, et al. HPV genotype distribution in Latino women. J Am Soc Cytopathol. 2014;4:42-48. doi:10.1016/j.jasc. 2014.10.004